Cargando…
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
High-throughput omics have proven invaluable in studying human disease, and yet day-to-day clinical practice still relies on physiological, non-omic markers. The metabolic syndrome, for example, is diagnosed and monitored by blood and urine indices such as blood cholesterol levels. Nevertheless, the...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BlackWell Publishing Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380926/ https://www.ncbi.nlm.nih.gov/pubmed/26148350 http://dx.doi.org/10.15252/msb.20145486 |